South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 4,305 shares at $6.07 ($26K) on 2023-03-16, disclosed to the SEC on 2023-03-20.
Open-market purchase of $26k RANI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.07 | 1,325 | $8K | 30.4% |
| 2 | $6.19 | 2,980 | $18K | 69.6% |
| Total | $6.15 avg | 4,305 | $26K | 100% |
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |